Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve audited standalone and consolidated ....
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has informed the stock exchanges that its Board of Directors will meet on 20th May 2025 to consider and approve the audited standalone and consolidated financial results for the quarter and full financial year ended 31st March 2025. The Board will also consider recommending a dividend, if any, on equity shares for FY25. The company's trading window for insiders is already closed since 1st April 2025 and will reopen 48 hours after the results are published. No financial numbers or business details have been disclosed in this filing.
This is a routine pre-results intimation with no immediate impact on the stock. Investors should watch for the actual results on 20th May 2025, particularly any dividend announcement which could be a positive trigger for shareholders.